Applying quality by design to vaccine development - BioProcess ...

More documents

Recommendations

Info

Influenza Vaccine Production: Viral PropagationRecombinant Seed Virus (New Isolate X Well‐growing strain)PrepareSubstrateInfect &IncubateRemove Cells,Purify VirusInactivate VirusEgg based…IncubateEmbryonated Eggs(1,000s needed)Cell based…Scale up cellculture from WCBInoculateAllantoic SacInfect inBioreactorHarvest AllantoicFluid, (10‐12ml/egg)Clarify, Ultra‐CentrifugeCentrifuge, TFF,ChromatographyTreat withformaldehydeSub‐unit vaccines arethen solvent‐extractedAttenuated live vaccinestreated to limitinfectivityFrom Clone to Clinic®
Recombinant Influenza VaccineIdentifyTarget StrainObtain sequence of antigeniccomponents (HA +/‐NA)GeneraterecombinantexpressionconstructGenerally requires no more than two weeksProduceRecombinantprotein or VLP onLarge ScaleHarvest, purify(protein or VLP)Fill/finish similar to standardbiopharmaceuticalsFrom Clone to Clinic®
Page 1 and 2: Application of Quality byDesign to
Page 4 and 5: ICH QbD Guidance‣ Q8 Pharmaceutic
Page 6 and 7: QbD for Vaccines‣ A‐VAX: Applyi
Page 8 and 9: What Does That Mean?‣ Systematic
Page 10 and 11: QbD Based on Scientific & Risk Base
Page 12 and 13: What are Critical Process Parameter
Page 14: Knowledge SpaceRef: B. Davis, FIP C
Page 17 and 18: Creating a Design Space: Putting it
Page 19 and 20: Design Space: Anion Exchange Column
Page 21 and 22: QbD Work Flow for Development of a
Page 23 and 24: Next Step: Target Product Profile (
Page 25 and 26: Control Strategy Vocabulary 1Termin
Page 27 and 28: QbD for Vaccines27From Clone to Cli
Page 29 and 30: Example:Application of QbD to Influ
Page 31 and 32: Diagram of Influenza VirusHemagglut
Page 33: A Wide Variety of Influenza A Strai
Page 37 and 38: expresSF+ Engineered for Vaccine Ma
Page 39 and 40: QbD in Influenza Vaccine Case Study
Page 41 and 42: Process Steps have Differing Sensit
Page 43 and 44: PSC SOP RG0006: a Framework for Flu
Page 45 and 46: RG0006 Governs the Variable Process
Page 47 and 48: Key Changes to H1 DSP Between 2009
Page 49 and 50: QbD and Influenza Vaccine-An Existi
Page 51 and 52: Acknowledgements‣ BioProcess Tech
Page 53: Follow us…www.bptc.comwww.bioproc

Applying quality by design to vaccine development - BioProcess ...

Create successful ePaper yourself

Delete template?

Save as template?